Silk Road Medical Inc
NASDAQ:SILK
Silk Road Medical Inc
NASDAQ:SILK
Price:
20.16 USD
3.7%
Market Closed
Updated:
May 2, 2024
Silk Road Medical Inc
Operating Income
|
Silk Road Medical Inc
Operating Income Peer Comparison
Comparables:
HAE
COO
XRAY
ALGN
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Silk Road Medical Inc
NASDAQ:SILK
|
Operating Income
-$59.3m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Haemonetics Corp
NYSE:HAE
|
Operating Income
$199.3m
|
CAGR 3-Years
24%
|
CAGR 5-Years
13%
|
CAGR 10-Years
4%
|
|
|
Cooper Companies Inc
NYSE:COO
|
Operating Income
$536.7m
|
CAGR 3-Years
17%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Operating Income
$296m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Operating Income
$663.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
14%
|
See Also
What is Silk Road Medical Inc's Operating Income?
Operating Income
-59.3m
USD
-59.3m
USD
Based on the financial report for Dec 31, 2023, Silk Road Medical Inc's Operating Income amounts to -59.3m USD.
What is Silk Road Medical Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-23%
-23%
Over the last year, the Operating Income growth was -14%. The average annual Operating Income growth rates for Silk Road Medical Inc have been -11% over the past three years , -23% over the past five years .
You don't have any saved screeners yet
